the most difficult part is holding a stock when its on super bull run. Every day u r tempted to take profit..end up ppl take the profit from u after u sell.
Ucrest stock is more or less cornered. Every tickets now is precious. Keyasic still not time but will rise as well due to spillover effect as too much fund interest in ucrest. Probably higher ratio to ucrest is better choice now. Hold key as well for another possible turn of event albeit smaller ratio.
Mth end profit result for key and will spark rally for keyasic jus like the initial stage of ucrest. So probably a multi yr reversal as well for key.
Dun forget, Mr Eg said keyasic is not involved in vaccine for NOW. If there's anything down the road he will make neccessary annoucement. So doesn't rule out future involvement.
For the vaccine new ventures. Theres 4 pt to note. Pt 1 is oem managment profit. 100m to 1bil x rm1 to rm 4 profit margin.
Pt 2 Sputnik efficacy track and trace service for many yrs to come.how many years? May be forever need monitor. Imedic huge penetration and permanent overhaul to revenue base. Millions user on imedic will make more n more healthcare join and adopt the imedic system. Snowball rolling effect will create millions of profit. These part will allow keyasic huge involvement. Billion user on imedic require billion chips and sd card and dongers. Huge investment in technology upgrade and service is needed. Vaccine and technology works hand in hand.
Pt 3. Future covid treatment drugs oem management for rdif. Another billion profit on track. This one comeout...crazy movement again.
Pt 4. Other vaccine manufacturer had approached ucrest to distribute their vaccine. Ucrest doesnt rule out become own distributors if they on firm note on oem manufacturing management. So for now kiv.
Russian RDIF (Russian Khazanah) coming to this region (south east asia), the most stability for now.... at least dont expect war lar or etc.... plus huge healthcare demand like what Mr Feng said....
for some, it is time to exit and take profit, for some, it is time to enter to get some profit, for some it is time to re-enter and make more profit...!
.... be careful ...... all the negative, naysayers, haters will start to surface ... probably they have missed the fatty worms..... still not too late to jump in !
Chill all my friend. This counter fundamental is way stronger than other goreng counter and better dont limit up. I prefer to grow steadily like UWC will do. Up faster will drop faster. So better keep it cool and steady.
those who think they missed the ship can still enter.. now still good price, but after tonight briefing.. i dont know la.. hehehe banker all come in liao u know its good sign
The best parts of UCrest in this vaccine deal are 1. Spunik is WHO approved 2. UCrest is local - Manufacturing in China, marketing by Russians - all approved. 3. Not under the control of Khairy's Ministry - local political uncertainty. 4. UCrest long relationship with Russia - (Putin ?)
Ucrest has been up lately, a little bit of a correction today: But Rakuten saw that many investors wanted a Chinese briefing, rakuten specially arranged for an investor who was interested to know: Our support for Rakuten will be their biggest motivation, and they will work harder to give us better investments briefing, seminar or event so that we retail investors can learn more about the company: Here's the message from Rakuten:- In response to a request from many investors who love and support UCrest:0005 for a briefing on Chinese, Rakuten is on Apr 20, 2021 at 8 p.m. a chinese investment briefing was held to share and analyze a memorandum signed between UCREST and the Russian Direct Investment Fund (RDIF) on the production of Sputnik V, a new Russian-developed vaccine satellite. This investment statement will be personally shared and explained by Mr. Wu Jiayi, Chairman of UCREST, with Chinese materials.
Due to the rapid and multi-pronged changes in the epidemic and vaccine market, Chairman Wu will also provide you with the latest developments in this project, I hope you will actively participate. Interested participants will be able to click on or enter the Facebook link above on their computer or mobile phone.
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
fms016
314 posts
Posted by fms016 > 2021-04-20 11:51 | Report Abuse
as usual, after Censof game over, Ucrest will overtake as the most traded share..